|
Nobuhisa Hagiwara
Department Other, Other Position |
|
| Language | English |
| Title | Impact of Baseline Low-Density Lipoprotein cholesterole Level and Aggressive Lipid-Lowering Therapy by Ezetimibe on Prognosis of Statin Naive Acute Coronary Syndrome Patients: A Sub-Analysis of the HIJ-PROPER Trial |
| Conference | American Heart Association (AHA) Scientific Sessions 2018 |
| Promoters | American Heart Association (AHA) |
| Conference Type | International society and overseas society |
| Presentation Type | Poster notice |
| Lecture Type | General |
| Publisher and common publisher | ◎WATANABE Erisa, YAMAGUCHI Junichi, SEKIGUCHI Haruki, IM Jihaeng, SUZUKI Keisuke, OGISO Masataka, ARASHI Hiroyuki, OGAWA Hiroshi, HAGIWARA Nobuhisa, and HIJ-PROPER Investigators |
| Date | 2018/11/10 |
| Venue (city and name of the country) |
Chicago, USA |
| Summary | *Session Title: Lipids, Lipoproteins and Risk of Coronary Artery Disease
Conclusions: In statin naïve ACS patients showing LDL-C value less than 140mg/dl on admission, intensive lipid lowering therapy, adding ezetimibe to pitavastatin, did not improve clinical outcome in comparison with pitavastatin monotherapy, regardless significant lower LDL-C value after 3-year. Another approach, other than ezetimibe, for lipid lowering should be warranted in this population. |